News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Alexey Kulikov/LinkedIn
Jun 19, 2025, 15:50

Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy

Alexey Kulikov, Head of Partnerships and Operations, Deputy Head of Secretariat for the UN NCD Task Force, and an External Relations Officer at WHO, shared a post on LinkedIn:

“Check this recent piece at The Lancet Group on Cancer vaccines and the future of immunotherapy.
Therapeutic vaccines training the immune system to eliminate established tumours are now showing real promise in clinical settings. In the adjuvant setting, vaccines against melanoma and pancreatic cancer appear to be reducing minimal residual disease and relapse. In the macrometastatic setting, in-situ vaccines have induced systemic regressions in advanced-stage lung and breast cancers and lymphomas.
More effective cancer vaccines are being developed through having a deeper understanding of crucial cellular factors in tumour immunology, the incorporation of newer vaccine components to effectively mobilise and activate cells, the use of omics and artificial intelligence in vaccine design, and addition of immune checkpoint blockade.
Review analyses cancer vaccine trials, the strengths and limitations of different vaccine approaches, and discuss how the next generation of cancer vaccines can help improve patient outcomes and quality of life.”

Title: Cancer vaccines and the future of immunotherapy

Authors: Orrin Pail, Matthew J Lin, Theodora Anagnostou, Brian D Brown, Joshua D Brody

You can read the Full Article on The Lancet Journal

Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy

More posts featuring Alexey Kulikov.

Alexey Kulikov Brian D. Brown cancer cancer vaccines immunotherapy Joshua D Brody Matthew J. Lin Melanoma OncoDaily Oncology Orrin Pail Pancreatic Cancer The Lancet Group Theodora Anagnostou
Special Coverage
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?
Drugs
Jun 19, 2025, 15:30
Graham Collins: Nivo-AVD vs BV-AVD in Older Patients (60+) with Hodgkin Lymphoma
Blog
Jun 19, 2025, 15:15
Antonio Jimenez Jimenez Shared Findings from the Multicenter ACCESS trial, Supported by CIBMTR and NMDP
Blog
Jun 19, 2025, 14:35
Peter Pisters: Pleased to Join the 1st Institute for Cell Therapy Discovery and Innovation's External Advisory Board meeting
Insight
Jun 19, 2025, 14:22
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
Blog
Jun 19, 2025, 13:04
Raul Cordoba Shared FOLL12 Trial on the Role of PET in Follicular Lymphoma
Oncolibrary
Jun 19, 2025, 13:01
Pancreatic Cancer Remission Rate: What Patients Should Know in 2025